First-ever financial toxicity tumor board aims to change the standard of care

Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Nearly half of cancer patients and survivors in the United States face medical debt so crushing that it has sparked a relatively new focus within oncology: financial toxicity.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login